Loading...
OTC Markets
Totals
Securities
12,388
Dollar Vol
$135.1M
Share Vol
9.5M
Trades
787

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

BIIB
Biogen Inc.

Common Stock
Biogen Inc. Company Logo

225 Binney Street

Cambridge, MA 02142

www.idecpharm.com

(617) 679-2000

Business Description
Not available
Financial Reporting
Reporting Status
U.S. Reporting: SEC Reporting
Audited Financials
Audited
Latest Report
CIK
0000875045
Fiscal Year End
12/31
Company Officers & Contacts
Thomas J. Bucknum
Secretary

Board of Directors

Not available

Other Company Insiders

Not available

Other Company Insiders are all persons or entities beneficially owning 10% or more of any class of the issuer's securities. Together, officers, directors and other company insiders comprise Company Insiders.
Service Providers

Not available

Profile Data
SIC - Industry Classification
2836 - Biological products, except diagnostic
Incorporation Information
DE, US
Employees
Not Available
Shell
No
Products and Services

Not available

Company Facilities

Not available

Company Notes
Formerly=Biogen Idec, Inc. until 3-2015
Formerly=IDEC Pharmaceuticals Corp. until 11-03
Note=6-97 State of Incorporation California changed to Delaware
Nasdaq
Daily Advancers